MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$213,475K
Net Income
$162,849K
Net Profit Margin
76.28%
EPS
$2.29
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
License and collaboration revenue
213,475
56,368
7,437
4,712
Research and development
42,061
46,739
46,358
40,003
General and administrative
12,648
13,277
11,434
11,130
Total operating expenses
54,709
60,016
57,792
51,133
Income (loss) from operations
158,766
-3,648
-50,355
-46,421
Interest income
6,429
5,876
6,761
7,049
Other (expense) income, net
-81
53
-124
33
Income (loss) before income tax expense
165,114
2,281
-43,718
-39,339
Income tax expense
2,265
-1,502
666
-
Net income (loss)
162,849
3,783
-44,384
-39,339
Basic EPS
2.47
0.06
-0.693
-0.62
Diluted EPS
2.29
0.05
-0.693
-0.62
Basic Average Shares
65,935,769
65,087,847
64,045,517
63,772,332
Diluted Average Shares
71,007,011
70,492,618
64,045,517
63,772,332
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
License and
collaboration revenue
$213,475K
(3749.17%↑ Y/Y)
Income (loss) from
operations
$158,766K
(477.65%↑ Y/Y)
Interest income
$6,429K
(-13.19%↓ Y/Y)
Total operating
expenses
$54,709K
(14.97%↑ Y/Y)
Income (loss) before
income tax expense
$165,114K
(577.22%↑ Y/Y)
Other (expense)
income, net
-$81K
(-325.00%↓ Y/Y)
Research and development
$42,061K
(13.57%↑ Y/Y)
General and
administrative
$12,648K
(19.87%↑ Y/Y)
Net income (loss)
$162,849K
(568.35%↑ Y/Y)
Income tax expense
$2,265K
(1216.86%↑ Y/Y)
Buy us a coffee
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics, Inc (PTGX)